Breaking News

ERT Reaches Data Milestone

By Kristin Brooks | January 8, 2014

Supports more than 300 successful NDAs

ERT has reached a milestone in data capture supporting the approval of new medical products. To date, global regulatory agencies have issued more than 300 approvals to biopharma companies that utilized ERT’s cardiac safety, respiratory, or eCOA solutions to capture safety and/or efficacy data in their clinical programs. ERT’s products and services for cardiac safety, respiratory, and eCOA include electronic patient reported outcomes (ePRO).
“It is extremely rewarding to realize that so many biopharmaceutical companies have brought new medical treatments to market using products and services delivered by ERT,” said Jeffrey Litwin, M.D., chief executive officer of ERT. “We are committed to delivering innovative and reliable solutions that meet the needs of our worldwide customers and supporting their efforts to bring life-enhancing and life-saving medical products to patients who need them.”

blog comments powered by Disqus
  • A Look at DCAT Week ‘16

    Tim Wright, Editor||January 28, 2016
    On the pulse of the pharmaceutical manufacturing value chain, DCAT Week ‘16 will deliver top-flight education programs and networking events.

  • Cold-Chain Logistics & The Central Lab

    Kristin Brooks, Associate Editor||January 28, 2016
    Eric Hayashi of LabConnect discusses safety measures to ensure sample integrity

  • CMC Biologics: Growing Through Innovation

    Tim Wright, Editor||January 28, 2016
    The new chief exec talks about industry trends and growth plans.